Anthony M Magliocco

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc., Erasmai LLC. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony M Magliocco. Retrieved from https://idiyas.com/inventor/anthony-m-magliocco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 80.0

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Tampa, FL (US) (2020)
Orlando, FL (US) (2022 - 2023)

Company Filing History:

4 out of 312

H. Lee Moffitt Cancer Center and Research Institute, Inc.

Years Active: 2020-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685479 - System for diagnosing Barrett's esophagus and related methods (2026-07-21),

2. 11643692 - Method of distinguishing lung squamous cell carcinoma from head and neck squamous cell carcinoma (2023-05-09),

3. 11618927 - Method of distinguishing urothelial carcinoma from lung and head and neck squamous cell carcinoma (2023-04-04),

4. 11360094 - Method for measuring MRE11 in tissues to predict cystectomy or bladder sparing surgery plus chemoradiation therapy (2022-06-14),

5. 10583183 - Immune gene signatures in urothelial carcinoma (UC) (2020-03-10),

Title: Anthony M. Magliocco: Innovator in Cancer Research

Introduction

Anthony M. Magliocco is a prominent inventor based in Orlando, FL (US). He has made significant contributions to the field of cancer research, particularly in the differentiation of various types of carcinomas. With a total of 5 patents to his name, his work has the potential to impact diagnostic methods in oncology.

Latest Patents

Magliocco's latest patents include innovative methods for distinguishing between different types of squamous cell carcinomas. One notable patent is a method that utilizes a 22-gene biomarker signature to differentiate lung squamous cell carcinoma from head and neck squamous cell carcinoma. Another significant patent presents a 19-gene signature that effectively distinguishes urothelial carcinoma from lung and head and neck squamous cell carcinomas, even when the primary site is unknown.

Career Highlights

Anthony M. Magliocco is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc. His work at this esteemed institution has allowed him to focus on groundbreaking research that aims to improve cancer diagnostics and treatment strategies.

Collaborations

Some of his notable coworkers include Yin Xiong and Soner Altiok. Their collaborative efforts contribute to the advancement of cancer research and the development of innovative diagnostic methods.

Conclusion

Anthony M. Magliocco's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient outcomes. His innovative methods for distinguishing between various carcinomas represent a significant advancement in the field.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: